Dr. Len's Cancer Blog

Dr. Len's Cancer Blog
American Cancer Society | Newsroom

Authored by J. Leonard (Len) Lichtenfeld, MD, the Society's deputy chief medical officer, this blog covers breaking cancer news and provides commentary on new research, scientific developments, and other cancer breakthroughs.

Content from this campaign

FDA: The Quality Problems Causing The Drug Shortage Were Not News To Those Making The Medicines
By Dr. Len Sometimes you have the opportunity to be educated, or to learn a bit more about a topic of importance. Yesterday was one of those opportunities. Attending a meeting (as an observer) of the National Cancer Institute Director's Consumer Liaison Group on the issue of...
Mar 12, 2012 1:30 PM ET
The Cancer Drug Shortage: Patients And Families Deserve Better
Does it get much worse than this? A story in the New York Times last week highlights the dwindling supply of the drug methotrexate, which is vital in the treatment of a form of childhood acute leukemia. The closure in November of a key manufacturing...
Feb 22, 2012 9:00 AM ET
So How Large Is Your Shadow?
This past Groundhog Day millions of people focused their attention on a furry little creature in Punxsutawney PA to see whether or not the animal sees its shadow. News bulletins say that he did, so we have six more weeks of...
Feb 13, 2012 2:00 PM ET
Sometimes Science Is Not Convenient: Avastin® In The (Very) Early Treatment Of Breast Cancer
Sometimes science is not as convenient as we would like it to be. We want answers, we want clarity, we want direction--especially when it comes to the treatment of patients with cancer.
Feb 3, 2012 10:00 AM ET
ACS Deputy Chief Medical Officer Shares his Thoughts on Some of the Most Memorable Cancer Headlines of 2011
According to Dr. Len Lichtenfeld, deputy chief medical officer of the American Cancer Society, we have made a substantial amount of progress in the treatment of cancer over the past few years, and 2011 has been exceptionally interesting. Here's his list of the top cancer headlines of 2011 and why they matter.
Dec 30, 2011 10:05 AM ET

Pages